BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 332.80
+0.40 (0.12%)
Feb 3, 2026, 3:15 PM CET
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of 29.46 billion as of February 3, 2026. Its market cap has increased by 63.73% in one year.
Market Cap
29.46B
Enterprise Value
27.63B
Revenue
1.92B
Ranking
n/a
PE Ratio
29.54
Stock Price
332.80
Market Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 2.55B to 29.46B, an increase of 1,053.78%. That is a compound annual growth rate of 34.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 29.46B | 6.95% |
| Dec 30, 2025 | 27.55B | 56.23% |
| Dec 30, 2024 | 17.63B | -25.44% |
| Dec 29, 2023 | 23.65B | -1.34% |
| Dec 30, 2022 | 23.97B | 128.37% |
| Dec 30, 2021 | 10.50B | 24.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camurus AB | 39.81B |
| Hansa Biopharma AB | 3.76B |
| Saniona AB | 3.64B |
| Vicore Pharma Holding AB | 3.14B |
| Flerie AB | 2.76B |
| Diamyd Medical AB | 2.13B |
| Egetis Therapeutics AB | 2.05B |
| BioInvent International AB | 1.95B |